PATENT CLAIM ANALYSIS

Application Number: 16100055
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2020-02
Patent Classification: ["null", "null"]

Abstract:
The invention relates to an oral formulation for targeted delivery of cholestyramine to the colon, comprising a plurality of cholestyramine pellets that are coated with a diffusion-controlled inner coating and an enteric outer coating. The invention also relates to the use of this formulation in the treatment of bile acid malabsorption.

Claim (Index 8):
The oral dosage form of  claim 7 , wherein each pellet comprises at least 90% w/w cholestyramine.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 96.0
- Lexical Diversity: 1.42105
- Patent Class: nan
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15988281', '15449781', '15988560', '15449645', '11804259']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5778612435953335
- 35 USC 102 Novelty (BERT): 0.5820513617578275
- Combined Prediction Score: 0.5782802554115829
- Mean Citation Score: 387.067998
- Max Citation Score: 548.3304400000002
- Similarity Product: 418.875234715717

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test